Professor Dr. Abu Kholdun Al Mahmood
Managing Director
Specialty - Professor & Head of the Department, Al Manar
Degree - MBBS, M Phil, Phd (Malaysia)
Executive Vice President and Chief Operating Officer
William C. Hahn, MD, PhD has been engaged in clinical care and research at Dana-Farber Cancer Institute since 1996. He is the William Rosenberg Professor of Medicine in the Department of Medical Oncology at Dana-Farber and Harvard Medical School, and an Institute Member of the Broad Institute of MIT and Harvard. He serves as an Executive Vice President and the Chief Operating Officer of Dana-Farber.
He received his AB in Biochemical Sciences, PhD in Immunology, and MD — all from Harvard University — and completed his clinical training at Massachusetts General Hospital and Dana-Farber. His research focuses on understanding how mutations cooperate in cancer initiation and progression to develop rational combination therapies.
Dr. Hahn has made numerous discoveries that have informed our current molecular understanding of cancer. His laboratory has pioneered the use of integrated functional genomic approaches to identify and validate cancer targets. He received multiple awards including the Wilson S. Stone Award (2000), the Ho-Am Prize in Medicine (2010), the Richard and Hinda Rosenthal Award (2015), the Claire and Richard Morse Award (2019), and the Hope Funds Award for Excellence in Medicine (2023). He is an elected member of multiple esteemed medical societies.